University College London (UCL)
London, W1W 7EJ, United Kingdom
NCT Number: NCT00922376
New telemedicine systems have been designed to assist people suffering from diabetes in the management of their chronic disease. More recently the focus has been moving to portable systems equipped with Bluetooth. This study consists of evaluating an application called the Think Positive (T+) diabetes management software. It is a randomized controlled trial designed to compare, over a nine month period, a group of patients receiving usual care with a group of patients using the T+ system. The objectives of the study are to investigate the extent to which this telemedicine application helps patients control their blood sugar levels (HbA1c), as well as the extent to which its users consider it to be acceptable. The impact of its use on factors such as diabetes self-care, health status, quality of life, self-confidence in diabetes management, fear of hypoglycemia and illness representations will also be examined. Because of the supplementary real-time support and feedback that T+ offers, its use should lead to better outcomes in diabetes management than usual care does.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
London, W1W 7EJ, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
T+ consists of the Glucometer paired with a cradle that transmits via Bluetooth blood glucose results to a mobile phone. Data is stored and sent to a secure website. The website can be accessed by the patient as well as by health care providers (HCP). HCP can discuss data on the phone and make recommendations via text messages to patients. Visual feedback (graphs and statistics) illustrating recent blood sugar levels patterns is automatically and immediately sent to the patient when data is transferred from the T+ phone.
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: 3 months, 9 months
Time frame: Baseline, 3 months, 9 months
Time frame: 3 months, 9 months
Time frame: baseline, 3 months, 9 months
Time frame: baseline, 3 months, 9 months
2 subscales of the HeiQ questionnaire.
University College London Hospitals
Other
Assessment of the Clinical Efficacy and Acceptability of the Think Positive (T+) Diabetes Management System in Insulin Requiring Diabetes
Acronym: T+
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06406439
Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes Mellitus
Gwangmyeong, Deokan-ro, South Korea
View Trial DetailsNCT07408141
Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes Mellitus
Chula Vista, California, United States
View Trial DetailsNCT07386613
Cardiovascular Diseases, Diabetes (DM)
Belfast, Belfast City, United Kingdom
View Trial DetailsNCT07141940
Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes Mellitus
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
View Trial Details